For Authors

Guides for Authors

Manuscripts must be submitted as a Word file (doc, docx). The figures should be submitted as separate files. Manuscripts should be no longer than 3500 words excluding the title page, abstract, and references (for reviews – 4000 words). The short communications (no more than 2500 words excluding the title page, abstract, and references) should be formatted in the same manner as full-length manuscripts.

The order of presentation for original contributions and short communications is the following:

Title Page should be on a separate page including a title, author(s)’ name(s) and their affiliation, the full address of corresponding authors (E-mail), postal code.

Abstract (maximum of 300 words) should be structured and contain such sub-sections as Background, Aim; Materials and Methods; Results; Conclusion; Key Words (up to six words). As a rule, the use of abbreviations and acronyms in the abstract should be limited. The footnotes or references are not allowed. Review article abstract (250 words) should be provided in unstructured paragraph format.

In general, the terms in the text of the paper should not be abbreviated unless they are conventional or used repeatedly and the abbreviation is helpful to the reader. The abbreviation should be given in brackets when the corresponding term is mentioned first time in the text. The list of abbreviations in an alphabetic order follows the abstract.

Introduction shouldprovide adequate background information, while avoiding a detailed literature review.

Materials and Methods. The details of the experimental procedures necessary for the understanding of the article should be provided except for the conventional techniques where only references may be given.

Chemical substances and drugs should be referred to by the generic name only. Trade names should not be used. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name and the name and location of the manufacturer in parentheses. The manufacturer’s name and country should be indicated for all chemicals and equipments.

All human and animal studies must have been approved by the relevant ethics committees. Papers, lacking such information, will not be considered.

The origin of cell lines used in the study should be clearly indicated.

The animal studies should include number of animals, their species, strain, line, ages, sex, weight and breeding, method of euthanasia.

The statistical methods used should be outlined. Provide the chosen level of significance and the name of the statistical package used (version, manufacturer, state).

Results. Only the major findings, along with numerical data, should be provided. Take care that the text does not repeat data that are presented in tables and/or figures.

Discussion. The findings and their implications should be discussed in the broadest context possible. The limitations of the present work should be highlighted. Future research directions may also be mentioned.

Acknowledgements, including identification of a source of a financial support, if such was provided.

References. The original contributions should have no more than 50 references (for short communications – 20, for reviews – 70). All references should be given in an order of citing. References should be indicated by Arabic numerals in the square brackets. Each reference should list the author’s last name, followed by all initials, a title of paper referred to, an abbreviated title of periodicals, year, volume number, and first and last page numbers. If there are more than three authors in a cited paper, only first three authors’ names should be provided, and a list should be continued by et al. Authors’ names and volume number should be in Bold. Responsibility for the accuracy of bibliographic references rests entirely with the author. Consult Index Medicus or PubMed for standard journal abbreviations. This journal should be cited as Exp Oncol. In press citations should be limited and must include the name of the journal that has accepted the paper. DOI should be indicated.

Examples:

Farria AT, Plummer JB, Salinger AP, et al. Transcriptional activation of MYC-induced genes by GCN5 promotes B-cell lymphomagenesis. Cancer Res 2020; 80: 5543-53. doi:10.1158/0008-5472.CAN-20-2379.

Mills AM, Longacre TA. Hereditary endometrial carcinoma. In: Deavers MT, Coffey DM, eds. Precision molecular pathology of uterine cancer. Cham, Switzerland: Springer International Publishing, 2017: 169-87. doi: 10.1007/978-3-319-57985-6.

Wild CP, Weiderpass E, Stewart BW, eds. World Cancer Report: cancer research for cancer prevention. Lyon, France: International Agency for Research on Cancer, 2020. 594 p.

NCI’s Division of Cancer Control and Population Sciences. Surveillance, Epidemiology and End Results Program. 2016. http://seer.cancer.gov/csr/1975_2013. Accessed November 29, 2016.

Tables.Create tables only using word processing software. The tables may be inserted into the body of text or given in separate sheets after the text. The title of the table should be given above and explanatory notes below the table. Explain in footnotes all abbreviations that are used in each table.The tables should be numbered with Arabic numerals and cited in the text.

Figures.All illustrations should be numbered in order of appearance with consecutive Arabic numerals. The Figures should be submitted as separate files (for each figure or a part of figure block). Curves or diagrams should be presented in .xls, .xlsx, .eps format. Illustrations should be presented as .tiff or .jpeg, with the resolution not less than 300 dpi; 80 mm size for 1 column (a half page width) or 165 mm for 2 columns (the full-page width).